ZA915861B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA915861B
ZA915861B ZA915861A ZA915861A ZA915861B ZA 915861 B ZA915861 B ZA 915861B ZA 915861 A ZA915861 A ZA 915861A ZA 915861 A ZA915861 A ZA 915861A ZA 915861 B ZA915861 B ZA 915861B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
ZA915861A
Other languages
English (en)
Inventor
Bruce Allan Ross
Allan Ross Bruce
Richard Victor Vivilecchia
Victor Vivilecchia Richard
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA915861B publication Critical patent/ZA915861B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA915861A 1990-07-25 1991-07-25 Pharmaceutical compositions ZA915861B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (1)

Publication Number Publication Date
ZA915861B true ZA915861B (en) 1993-03-31

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915861A ZA915861B (en) 1990-07-25 1991-07-25 Pharmaceutical compositions

Country Status (30)

Country Link
EP (1) EP0468929B1 (sv)
JP (1) JP2502849B2 (sv)
KR (1) KR100227156B1 (sv)
AT (1) AT400519B (sv)
AU (1) AU639354B2 (sv)
CA (1) CA2047802C (sv)
CH (1) CH683150A5 (sv)
CZ (1) CZ280184B6 (sv)
DE (1) DE4124409B4 (sv)
DK (1) DK0468929T3 (sv)
ES (1) ES2061218T3 (sv)
FI (1) FI98127C (sv)
GB (1) GB2246296B (sv)
HU (1) HU222489B1 (sv)
IE (1) IE66184B1 (sv)
IL (1) IL98934A (sv)
IT (1) IT1290797B1 (sv)
LU (1) LU87980A1 (sv)
MX (1) MX9100357A (sv)
MY (1) MY107183A (sv)
NO (1) NO912872D0 (sv)
NZ (1) NZ239078A (sv)
PL (1) PL167712B1 (sv)
PT (1) PT98417B (sv)
RU (1) RU2075310C1 (sv)
SA (1) SA92130106B1 (sv)
SK (1) SK278563B6 (sv)
TW (1) TW212757B (sv)
UA (1) UA26064A1 (sv)
ZA (1) ZA915861B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2942495A (en) * 1994-07-13 1996-02-16 Lek Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
HUP0102260A3 (en) 1998-06-05 2002-12-28 Warner Lambert Co Stabilization of compositions containing ace inhibitors using magnesium oxide
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) † 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
AU2003235579A1 (en) * 2002-01-15 2003-07-30 Delta Hf. Formulations of quinapril and related ace inhibitors
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
CN110662534A (zh) 2017-05-31 2020-01-07 勃林格殷格翰国际有限公司 包含(e)-4-(2-(氨基甲基)-3-氟烯丙基氧基)-n-叔丁基苯甲酰胺的药物组合物和药物剂型，其制备方法、治疗方法及用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
HU9102385D0 (en) 1991-12-30
NO912872D0 (no) 1991-07-23
FI98127C (sv) 1997-04-25
JPH04253923A (ja) 1992-09-09
GB9115893D0 (en) 1991-09-04
CH683150A5 (de) 1994-01-31
JP2502849B2 (ja) 1996-05-29
IL98934A0 (en) 1992-07-15
TW212757B (sv) 1993-09-11
DE4124409B4 (de) 2004-11-18
MX9100357A (es) 1992-02-28
CA2047802A1 (en) 1992-01-26
FI913554A (sv) 1992-01-26
NZ239078A (en) 1993-10-26
EP0468929A3 (en) 1992-02-19
DK0468929T3 (da) 1994-12-27
UA26064A1 (uk) 1999-04-30
PT98417B (pt) 1999-01-29
LU87980A1 (fr) 1993-02-15
KR100227156B1 (ko) 1999-10-15
ATA147691A (de) 1995-06-15
DE4124409A1 (de) 1992-01-30
PL167712B1 (en) 1995-10-31
IE66184B1 (en) 1995-12-13
AT400519B (de) 1996-01-25
HUT59819A (en) 1992-07-28
AU639354B2 (en) 1993-07-22
CZ280184B6 (cs) 1995-11-15
CA2047802C (en) 2003-05-06
FI913554A0 (sv) 1991-07-24
PL291219A1 (en) 1992-08-24
IL98934A (en) 1996-07-23
ES2061218T3 (es) 1994-12-01
AU8128691A (en) 1992-01-30
IT1290797B1 (it) 1998-12-11
HU222489B1 (hu) 2003-07-28
SA92130106B1 (ar) 2005-10-16
SK278563B6 (en) 1997-10-08
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
FI98127B (sv) 1997-01-15
ITRM910554A1 (it) 1993-01-23
RU2075310C1 (ru) 1997-03-20
CS230991A3 (en) 1992-04-15
IE912608A1 (en) 1992-01-29
ITRM910554A0 (it) 1991-07-23
PT98417A (pt) 1992-06-30
MY107183A (en) 1995-09-30
EP0468929A2 (en) 1992-01-29
EP0468929B1 (en) 1994-09-28
KR920002146A (ko) 1992-02-28

Similar Documents

Publication Publication Date Title
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
ZA915861B (en) Pharmaceutical compositions
GB9100465D0 (en) Pharmaceutical compositions
GB9111314D0 (en) Pharmaceutical compositions
GB9023023D0 (en) Pharmaceutical compositions
GB9115693D0 (en) Solid pharmaceutical compositions
GB9026080D0 (en) Pharmaceutical compositions
GB9003185D0 (en) Pharmaceutical compositions
ZA917596B (en) Pharmaceutical compositions
GB9221212D0 (en) Pharmaceutical compositions
GB9115156D0 (en) Pharmaceutical compositions
GB9015418D0 (en) Pharmaceutical compositions
ZA915450B (en) Pharmaceutical composition
GB9022025D0 (en) Pharmaceutical compositions
GB9017202D0 (en) Pharmaceutical compositions
GB9413572D0 (en) Pharmaceutical compositions
GB9014736D0 (en) Pharmaceutical compositions
IL94075A0 (en) Pharmaceutical compositions
ZA919715B (en) Pharmaceutical compositions
GB9002351D0 (en) Pharmaceutical compositions
GB9021476D0 (en) Pharmaceutical compositions
ZW10690A1 (en) Pharmaceutical compositions
GB9016660D0 (en) Pharmaceutical compositions
GB9027605D0 (en) Pharmaceutical compositions
GB9026476D0 (en) Pharmaceutical compositions